Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Tuberculosis in Prisons

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Age above 18 and under 45 at the time of inclusion;~* Sign the informed consent form.~Exclusion criteria:~* Be indigenous;~* Active TB or previous use of isoniazid;~* Score Alcohol Use Disorders Identification Test ≥15.~* Reactive serology for HIV, hepatitis B and C;~* Reactive result for quantiferon, considering as positive the result of Tube 1 and / or Tube22 above 0.2 IU / mL;~* Liver enzymes (Aspartate aminotransferase and Alanate aminotransferase) three times the upper limit;~* History or treatment for epilepsy;

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Treatment (Type: EXPERIMENTAL): Each subject received two oral supervised weekly doses of isoniazid 900 milligrams.
- Control (Type: PLACEBO_COMPARATOR): Each subject received two oral supervised weekly doses of placebo (oral tablet, without the active ingredient, similar in size, weight, color, taste and odor).

Based on this trial design, predict the completion outcome and termination type (if applicable).